Listing Details
- Listing Exchange NSE SME
- Listing Date 13-Sep-23
- IPO Price Range ₹ 84
- Listing Price ₹ 65
- Listing Change -22.6%
- Last Traded Price ₹ 46.95
- Current Change -44.1%
Saroja Pharma IPO Details
- Open Date 31-Aug-23
- Close Date 05-Sep-23
- Lot Size 1600
- IPO Size ₹ 9.11 Cr
- IPO Price Range ₹ 84
- Min Investment ₹ 134,400
- Listing Exchange NSE SME
- Basis of Allotment 08-Sep-23
- Refunds 11-Sep-23
- Credit to Demat Account 12-Sep-23
- Listing Date 13-Sep-23
Saroja Pharma Industries India IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 31-Aug-23 | - | 0.11 | 1.58 | 0.79 |
| 01-Sep-23 | - | 0.49 | 3.75 | 2.12 |
| 04-Sep-23 | - | 1.14 | 7.51 | 4.33 |
| 05-Sep-23 | - | 2.90 | 14.74 | 8.83 |
Saroja Pharma IPO Synopsis
Saroja Pharma Industries India Limited IPO is all set to open from 31st August to 5th September 2023. The company is in the business of trading, exporting and supplying Specialty Chemicals & API. The IPO includes a fresh issue of 10,84,800 shares worth ₹9.11 cr. The share allotment date is 8th September, and the IPO will be listed on 13th September on the stock exchanges. The price is ₹84 per share and the lot size is 1600 shares.
Swastika Investmart Limited is the book-running lead manager for this IPO, while Kfin Technologies Limited is the registrar.
Objectives of Saroja Pharma Industries IPO:
Saroja Pharma Industries plans to utilize the raised capital from the IPO to:
● To fund a manufacturing unit
● To repay the outstanding unsecured loans
● To meet the public issue expense
About Saroja Pharma Industries India
Established in 2019, Saroja Pharma Industries was established with the primary goal of providing the best service in chemical trading, with premium pharmaceutical companies in India and abroad to offer cost-effective solutions in human and veterinary medicine. The company specializes in trading Pharma API, Pharma Intermediates, Chemicals, and Solvents, all essential for the production of pharmaceutical and medical products.
Saroja Pharma has three distinct product categories: i) Chemicals ii) Pharma Intermediaries iii) Veterinary Pharma API. It offers a wide range of products including Liquide Bromine, utilized as an agro-intermediate, as well as Ethyl Acetate, serving as an API solvent.
The company also exports products to Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.
Peer Comparison
● NGL Fine Chem Limited
● Sequent Scientific Limited
For More Information:
Webstory on Saroja Pharma IPO
Saroja Pharma Industries India Financial Status
Profit and Loss
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue | 50.19 | 55.63 | 36.66 |
| EBITDA | 2.87 | 2.42 | 1.38 |
| PAT | 1.06 | 1.14 | 0.73 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Total Assets | 21.34 | 15.51 | 8.22 |
| Share Capital | 2.93 | 0.22 | 0.01 |
| Total Borrowings | 16.25 | 11.48 | 7.28 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | 2.19 | -3.67 | -1.04 |
| Net cash from / (used in) investing activities | -4.82 | -0.33 | -0.05 |
| Net cash flow from / (used in) financing activities | 2.73 | 4.26 | 1.02 |
| Net increase (decrease) in cash and cash equivalents | 0.099 | 0.26 | -0.07 |
Saroja Pharma IPO Key Points
-
Strengths
1. The company has a scalable business model.
2. Vast product portfolio.
3. The company’s operation and revenue base are diverse.
4. Experienced promoters and management.
-
Risks
1. Domestic sales are dependent on only five States in India.
2. Negative cash flows in the past.
3. The company can be impacted by forex fluctuations.
4. Operates in a highly competitive industry.
How to apply for IPO?
-
Login to your 5paisa account and select the issue in the
current IPO section -
Enter the number of lots and price at which you wish to
apply for -
Enter your UPI ID and click on submit. With this, your
bid will be placed with the exchange -
You will receive a mandate notification to block funds in
your UPI app -
Approve the mandate request on your UPI and funds
will be blocked
Open account in 5 minutes
Be a part of the 5paisa community now with 10 million mobile app users
Saroja Pharma IPO FAQs
What is the minimum lot size and investment required for the Saroja Pharma Industries IPO?
The minimum lot size of Saroja Pharma Industries IPO is 1600 shares and the investment required is ₹1,34,400.
What is the price band of Saroja Pharma Industries IPO?
The price band of Saroja Pharma Industries IPO is ₹84 per share.
When does the Saroja Pharma Industries IPO opens and closes?
Saroja Pharma Industries IPO opens from 31st August to 5th September 2023.
What is the size of the Saroja Pharma Industries IPO?
The size of Saroja Pharma Industries IPO is ₹9.11 cr.
What is the allotment date of the Saroja Pharma Industries IPO?
The share allotment date of Saroja Pharma Industries IPO is 8th September 2023.
What is the Saroja Pharma Industries IPO listing date?
The Saroja Pharma Industries IPO will be listed on 13th September 2023.
Who are the book runners for the Saroja Pharma Industries IPO?
Swastika Investmart Limited is the book-running lead manager for Saroja Pharma Industries IPO.
What is the objective of Saroja Pharma Industries IPO?
Saroja Pharma Industries plans to utilize the raised capital from the IPO to:
1. To fund a manufacturing unit
2. To repay the outstanding unsecured loans
3. To meet the public issue expense
How to apply for the Saroja Pharma Industries IPO?
To apply for Saroja Pharma Industries IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Saroja Pharma Industries IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
● You will receive a mandate notification to block funds in your UPI app.
Contact Details of Saroja Pharma Industries India IPO
Contact Information
Saroja Pharma Industries India Limited
305, Kailash Tower, Shiv Shristi Complex,
Goregaon Link Road, Mulund West,
Mumbai (MH) – 400080
Phone: +91 (022) 2081 0011
Email: info@sarojapharma.com
Website: https://www.sarojapharma.com/
Saroja Pharma Industries India IPO Register
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: spiil.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Saroja Pharma Industries India IPO Lead Manager
Swastika Investmart Ltd.